Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1023667Generated: October 27, 2026

Potassium Hydroxide → Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate

https://huagongshe.com/reaction/1023667

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium HydroxideHCID 14797—
ReactantRaltegravirHCID 54671008—
SolventWater ethanolHCID 19096565—
ProductPotassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olateHCID 23668479—

Reaction Conditions

Temperature50 °C

Reaction Steps

A vial (20 ml) was charged with Raltegravir free hydroxy (200 mg) slurry in EtOH:H2O (1000:1, 0.2 ml) at room temperature. The slurry was heated to 50° C. A solution of 45% aqueous KOH (0.044 ml) was added at 50° C. to the mixture. The resulting mixture was stirred for 5.5 h at 50° C. To this mixture was added distilled H2O (1.5 ml) dropwise to produce a colorless solution. The solvent was then removed under reduced pressure to provide wet Raltegravir potassium crystalline Form VI. The product was dried in a vacuum oven at 40° C. for 3.5 hours to provide Raltegravir potassium crystalline Form VI.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08722722B2
Source datasetuspto-grants-2014_05
ORD IDord-8b662a9313324e57bc606751f3d7be7b
Source noteuspto-grants-2014_05